Specifically, it has been demonstrated that immunomodulatory drugs (IMiDs), except for thalidomide, induce PD-L1 expression on IMiDs-resistant HMCLs and primary PCs from relapsed/refractory MM patients (RR-MM). The gene discussed is CD274; the disease is Miyoshi myopathy.